Rho kinase inhibitor for primary open‐angle glaucoma and ocular hypertension
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Rho Kinase Inhibitor for Primary Open‐angle Glaucoma and Ocular Hypertension." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436789/all/Rho_kinase_inhibitor_for_primary_open‐angle_glaucoma_and_ocular_hypertension_New. Accessed 20 April 2024.
Rho kinase inhibitor for primary open‐angle glaucoma and ocular hypertension. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436789/all/Rho_kinase_inhibitor_for_primary_open‐angle_glaucoma_and_ocular_hypertension_New. Accessed April 20, 2024.
Rho kinase inhibitor for primary open‐angle glaucoma and ocular hypertension. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/436789/all/Rho_kinase_inhibitor_for_primary_open‐angle_glaucoma_and_ocular_hypertension_New
Rho Kinase Inhibitor for Primary Open‐angle Glaucoma and Ocular Hypertension [Internet]. In: Cochrane Abstracts. [cited 2024 April 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436789/all/Rho_kinase_inhibitor_for_primary_open‐angle_glaucoma_and_ocular_hypertension_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rho kinase inhibitor for primary open‐angle glaucoma and ocular hypertension
ID - 436789
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436789/all/Rho_kinase_inhibitor_for_primary_open‐angle_glaucoma_and_ocular_hypertension_New
DB - Evidence Central
DP - Unbound Medicine
ER -